Jupiter Neurosciences, Inc (JUNS) Diversifiers

Equity · Currency in USD · Last updated Jun 5, 2026

Jupiter Neurosciences, Inc. develops resveratrol-based therapeutic products targeting neuroinflammation, with multiple drug candidates in Phase II trials for rare neurological and neurodegenerative diseases such as Friedreich's Ataxia, mild cognitive impairment/early Alzheimer's, mucopolysaccharidosis type 1, mitochondrial encephalopathy, and Parkinson's disease. The company also partners to advance clinical trials and develop consumer nutritional products focused on longevity, aging, and healthspan.

Looking to balance out your exposure to JUNS? The ETFs below have the lowest correlation with JUNS — they tend to move on their own, which can help reduce risk when JUNS drops. The stock ideas table highlights individual companies that behave independently from JUNS.

No Diversifiers Found for JUNS

We do not have enough correlation history to rank diversifiers for this symbol yet.

Diversification Analysis

Build a portfolio that complements JUNS

Add JUNS to the Diversification Analyzer to see how it overlaps with your other holdings and which assets balance it best.

Analyze a portfolio with JUNS